Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial
Authors:
Top Cited Papers
Open Access
- 2 November 2023
- journal article
- research article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 12 (1) , 67-77
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A re-randomisation design for clinical trialsBMC Medical Research Methodology, 2015
- Fitting Linear Mixed-Effects Models Usinglme42015
- Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trialThe Lancet, 2013
- Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary diseaseThorax, 2012
- Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their BiomarkersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized TrialsAnnals of Internal Medicine, 2010
- Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2003
- Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trialThe Lancet, 1999